Development of a gene signature associated with iron metabolism in lung adenocarcinoma

References

• Hirsch FR, Scagliotti GV, Mulshine JL, et al. Lung cancer: current therapies and new targeted treatments. Lancet. 2017;389(10066):299–311.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Shi J, Hua X, Zhu B, et al. Somatic genomics and clinical features of lung adenocarcinoma: a retrospective study. PLoS Med. 2016;13(12):e1002162.
   PubMed Web of Science ®Google Scholar
• Torti SV, Manz DH, Paul BT, et al. Iron and Cancer. Annu Rev Nutr. 2018;38(1):97–125.
   PubMedGoogle Scholar
• Greene CJ, Attwood K, Sharma NJ, et al. Transferrin receptor 1 upregulation in primary tumor and downregulation in benign kidney is associated with progression and mortality in renal cell carcinoma patients. Oncotarget. 2017;8(63):107052.
   PubMedGoogle Scholar
• Kuang Y, Wang Q. Iron and lung cancer. Cancer Lett. 2019;464:56–61.
   PubMed Web of Science ®Google Scholar
• Jung M, Mertens C, Tomat E, et al. Iron as a Central Player and Promising Target in Cancer Progression. Int J Mol Sci. 2019;20(2):273.
   Web of Science ®Google Scholar
• Sukiennicki GM, Marciniak W, Muszynska M, et al. Iron levels, genes involved in iron metabolism and antioxidative processes and lung cancer incidence. PLoS One. 2019;14(1):e0208610.
   PubMed Web of Science ®Google Scholar
• Gupta A, Srivastava S, Prasad R, et al. Oxidative stress in non-small cell lung cancer patients after chemotherapy: association with treatment response. Respirology. 2010;15(2):349–356.
   PubMed Web of Science ®Google Scholar
• Carpagnano GE, Lacedonia D, Palladino GP, et al. Could exhaled ferritin and SOD be used as markers for lung cancer and prognosis prediction purposes? Eur J Clin Invest. 2012;42(5):478–486.
   PubMed Web of Science ®Google Scholar
• Kinnula VL, Crapo JD. Superoxide dismutases in the lung and human lung diseases. Am J Respir Crit Care Med. 2003;167(12):1600–1619.
   PubMed Web of Science ®Google Scholar
• Cox R, Gyde OH, Leyland MJ. Serum ferritin levels in small cell lung cancer. European journal of cancer & clinical oncology. 1986;22(7):831–835.
   PubMedGoogle Scholar
• Chanvorachote P, Luanpitpong S. Iron induces cancer stem cells and aggressive phenotypes in human lung cancer cells. Am J Physiol Cell Physiol. 2016;310(9):C728–739.
   PubMed Web of Science ®Google Scholar
• Mounir M, Lucchetta M, Silva TC, et al. New functionalities in the TCGAbiolinks package for the study and integration of cancer data from GDC and GTEx. PLoS Comput Biol. 2019;15(3):e1006701.
   PubMed Web of Science ®Google Scholar
• Leek JT, Johnson WE, Parker HS, et al. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics. 2012;28(6):882–883.
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Morris JH, Cook H, et al. The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res. 2017;45(D1):D362–D368.
   PubMed Web of Science ®Google Scholar
• Vasquez MM, Hu C, Roe DJ, et al. Least absolute shrinkage and selection operator type methods for the identification of serum biomarkers of overweight and obesity: simulation and application. BMC Med Res Methodol. 2016;16(1):154.
   PubMedGoogle Scholar
• Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33(1):1.
   PubMed Web of Science ®Google Scholar
• Lacny S, Wilson T, Clement F, et al. Kaplan-Meier survival analysis overestimates cumulative incidence of health-related events in competing risk settings: a meta-analysis. J Clin Epidemiol. 2018;93:25–35.
   PubMed Web of Science ®Google Scholar
• Kamarudin AN, Cox T, Kolamunnage-Dona R. Time-dependent ROC curve analysis in medical research: current methods and applications. BMC Med Res Methodol. 2017;17(1):53.
   PubMedGoogle Scholar
• Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Nat Acad Sci. 2005;102(43):15545–15550.
   PubMed Web of Science ®Google Scholar
• Yoshihara K, Shahmoradgoli M, Martinez E, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4(1):2612.
   PubMed Web of Science ®Google Scholar
• Rooney MS, Shukla SA, Wu CJ, et al. Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell. 2015;160(1–2):48–61.
   PubMed Web of Science ®Google Scholar
• Recalcati S, Gammella E, Cairo G. Dysregulation of iron metabolism in cancer stem cells. Free Radic Biol Med. 2019;133:216–220.
   PubMed Web of Science ®Google Scholar
• Bogdan AR, Miyazawa M, Hashimoto K, et al. Regulators of Iron homeostasis: new players in metabolism, cell death, and disease. Trends Biochem Sci. 2016;41(3):274–286.
   PubMed Web of Science ®Google Scholar
• Du P, Xiong R, Li X, et al. Immune regulation and antitumor effect of TIM-1. J Immunol Res. 2016;2016:8605134.
   PubMed Web of Science ®Google Scholar
• Rennert PD. Novel roles for TIM-1 in immunity and infection. Immunol Lett. 2011;141(1):28–35.
   PubMed Web of Science ®Google Scholar
• Zheng X, Xu K, Chen L, et al. Prognostic value of TIM-1 expression in human non-small-cell lung cancer. J Transl Med. 2019;17(1):178.
   PubMedGoogle Scholar
• Hao L, Zhou X, Liu S, et al. Elevated GAPDH expression is associated with the proliferation and invasion of lung and esophageal squamous cell carcinomas. Proteomics. 2015;15(17):3087–3100.
   PubMed Web of Science ®Google Scholar
• Zhu X, Guo X, Wu S, et al. ANGPTL4 correlates with NSCLC Progression And Regulates Epithelial-Mesenchymal transition via ERK pathway. Lung. 2016;194(4):637–646.
   PubMed Web of Science ®Google Scholar
• Ma H, Hockla A, Mehner C, et al. PRSS3/Mesotrypsin and kallikrein-related peptidase 5 are associated with poor prognosis and contribute to tumor cell invasion and growth in lung adenocarcinoma. Sci Rep. 2019;9(1):1844.
   PubMedGoogle Scholar
• Xie L, Dang Y, Guo J, et al. High KRT8 expression independently predicts poor prognosis for lung adenocarcinoma patients. Genes (Basel). 2019;10(1):36.
   Web of Science ®Google Scholar
• Jin L, Chun J, Pan C, et al. Phosphorylation-mediated activation of LDHA promotes cancer cell invasion and tumour metastasis. Oncogene. 2017;36(27):3797–3806.
   PubMed Web of Science ®Google Scholar
• Yu C, Hou L, Cui H, et al. LDHA upregulation independently predicts poor survival in lung adenocarcinoma, but not in lung squamous cell carcinoma. Future Oncol. 2018;14(24):2483–2492.
   PubMed Web of Science ®Google Scholar
• Song YJ, Tan J, Gao XH, et al. Integrated analysis reveals key genes with prognostic value in lung adenocarcinoma. Cancer Manag Res. 2018;10:6097–6108.
   PubMed Web of Science ®Google Scholar
• Li W, Pan T, Jiang W, et al. HCG18/miR-34a-5p/HMMR axis accelerates the progression of lung adenocarcinoma. Biomed Pharmacother. 2020;129:110217.
   PubMed Web of Science ®Google Scholar
• Ooi AT, Gomperts BN. Molecular pathways: targeting cellular energy metabolism in cancer via inhibition of SLC2A1 and LDHA. Clin Cancer Res. 2015;21(11):2440–2444.
   PubMed Web of Science ®Google Scholar
• Shiratsuchi H, Wang Z, Chen G, et al. Oncogenic Potential of CYP24A1 in Lung Adenocarcinoma. J Thorac Oncol. 2017;12(2):269–280.
   PubMed Web of Science ®Google Scholar
• Moon HJ, Finney J, Ronnebaum T, et al. Human lysyl oxidase-like 2. Bioorg Chem. 2014;57:231–241.
   PubMed Web of Science ®Google Scholar
• Peng DH, Ungewiss C, Tong P, et al. ZEB1 induces LOXL2-mediated collagen stabilization and deposition in the extracellular matrix to drive lung cancer invasion and metastasis. Oncogene. 2017;36(14):1925–1938.
   PubMed Web of Science ®Google Scholar
• An HJ, Lee YJ, Hong SA, et al. The prognostic role of tissue and serum MMP-1 and TIMP-1 expression in patients with non-small cell lung cancer. Pathol Res Pract. 2016;212(5):357–364.
   PubMed Web of Science ®Google Scholar
• Djenidi F, Adam J, Goubar A, et al. CD8+ CD103+ Tumor–Infiltrating lymphocytes are tumor-specific tissue-resident memory t cells and a prognostic factor for survival in lung cancer patients. J Immunol. 2015;194(7):3475–3486.
   PubMed Web of Science ®Google Scholar
• Stankovic B, Bjorhovde HAK, Skarshaug R, et al. Immune cell composition in human Non-small Cell Lung Cancer. Front Immunol. 2018;9:3101.
   PubMed Web of Science ®Google Scholar
• Welsh TJ, Green RH, Richardson D, et al. Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer. J Clin Oncol. 2005;23(35):8959–8967.
   PubMed Web of Science ®Google Scholar